Prothena Corporation plc (PRTA)

NASDAQ
25.75
-0.20(-0.77%)
After Hours
25.79
+0.04(+0.16%)
- Real-time Data
  • Volume:
    320,811
  • Day's Range:
    25.33 - 26.26
  • 52 wk Range:
    23.82 - 79.75

PRTA Overview

Prev. Close
25.95
Day's Range
25.33-26.26
Revenue
201.56M
Open
25.55
52 wk Range
23.82-79.75
EPS
1.23
Volume
320,811
Market Cap
1.21B
Dividend (Yield)
N/A
(N/A)
Average Vol. (3m)
422,106
P/E Ratio
21.13
Beta
1.39
1-Year Change
1.94%
Shares Outstanding
46,806,224
Next Earnings Date
Aug 09, 2022
What is your sentiment on Prothena?
or
Market is currently closed. Voting is open during market hours.

Prothena Corporation plc News

Prothena Corporation plc Analysis

Prothena Corporation plc Company Profile

Prothena Corporation plc Company Profile

Employees
82

Prothena Corporation plc, a late-stage clinical company, focuses on discovery and development of novel therapies for life-threatening diseases in the United States. The company is involved in developing Birtamimab, an investigational humanized antibody that is in Phase III clinical trial for the treatment of AL amyloidosis; Prasinezumab, a humanized monoclonal antibody, which is in Phase IIb clinical trial for the treatment of Parkinson’s disease; PRX004 that completed Phase I clinical trial for the treatment of Transthyretin amyloidosis; and PRX005, which is in Phase I clinical trial for the treatment of Alzheimer’s disease. Its discovery and preclinical programs include PRX012 for the treatment of Alzheimer’s disease; and dual Aß-Tau vaccine for the treatment and prevention of Alzheimer’s disease. Prothena Corporation plc has a license, development, and commercialization agreement with F. Hoffmann-La Roche Ltd. and Hoffmann-La Roche Inc. to develop and commercialize antibodies that target alpha-synuclein; and a collaboration agreement with Bristol-Myers Squibb to develop antibodies. The company was founded in 2012 and is based in Dublin, Ireland.

Read More

Technical Summary

Type
5 Min
15 Min
Hourly
Daily
Monthly
Moving AveragesSellSellSellStrong SellSell
Technical IndicatorsStrong SellNeutralSellStrong SellStrong Sell
SummaryStrong SellNeutralSellStrong SellStrong Sell
  • Wow
    0
    • 🚀
      0